Skip to main content
. Author manuscript; available in PMC: 2013 Feb 4.
Published in final edited form as: Transplantation. 2011 May 27;91(10):1153–1158. doi: 10.1097/TP.0b013e3182157d60

FIGURE 1.

FIGURE 1

Posttransplant human leukocyte antigen (HLA) and major histocompatibility complex class I chain-related antigens A (MICA) donor-specific antibodies (DSA) increases the probability of transplant coronary artery disease (TCAD). TCAD-free survival at 2 years posttransplant was significantly lower in the 26 patients with anti-donor HLA and MICA antibodies compared with 46 patients without DSA (P<0.02).